You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Treatment dilemma for survivors of rituximab-induced bowel perforation in the setting of post-transplant lymphoproliferative disorder

Article info

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Treatment dilemma for survivors of rituximab-induced bowel perforation in the setting of post-transplant lymphoproliferative disorder

Authors

  1. Correspondence to Dr Brianne J Sullivan, brianne.sullivan@mountsinai.org
View Full Text

Citation

Sullivan BJ, Kim GJ, Sara G
Treatment dilemma for survivors of rituximab-induced bowel perforation in the setting of post-transplant lymphoproliferative disorder
BMJ Case Reports CP 2018;11:e226666.

Publication history

  • Accepted October 24, 2018
  • First published December 13, 2018.
Online issue publication 
January 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.